Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: genetics

The Genetics of Living Longer: Study Challenges Decades of Aging Research

What determines how long people live, and how much of their lifespan is influenced by genetics?

For many years, scientists believed the genetic contribution to human lifespan was relatively modest compared with other biological traits. Earlier estimates placed the heritability of lifespan at around 20 to 25 percent, and some more recent large studies suggested it might be even lower, in some cases below 10 percent.

A new study from the Weizmann Institute of Science now challenges that view. The research, published in the journal Science, reports that genetic differences may account for roughly half of the variation in human lifespan. This estimate is more than double many previous calculations. The work was led by Ben Shenhar in the laboratory of Prof. Uri Alon of the Weizmann Institute’s Molecular Cell Biology Department.

New DNA tools outperform traditional methods for detecting genetic risk in wildlife

Wildlife populations that become small and isolated, often due to habitat loss, inevitably experience inbreeding which can lead to the loss of fitness and eventual extinction. One solution is to perform a genetic rescue: a management intervention where new blood is brought in by introducing outsiders to a population to reduce inbreeding and restore diversity. But how do researchers know the inbreeding problem has been solved?

A new long-term study from Western, led by biology professor and chair David Coltman, shows DNA-based tools detected changes in inbreeding more accurately than traditional pedigree methods in a wild population of bighorn sheep that was recently genetically rescued. The study was published in the journal Evolutionary Applications.

Pedigree approaches estimate genetic health from family history, whereas genomic approaches directly analyze DNA.

Oligodendrocyte molecular perturbations associated with tau in Alzheimer’s

The findings suggest that in AD, part of what happens in the brain may involve changes in DNA tagging that affect the function of oligodendrocytes, particularly in relation to the buildup of the toxic protein tau.

Oligodendrocytes are the brain cells that make myelin, the insulation that helps nerve cells communicate. Scientists have theorized that disrupting neuron communication contributes to symptoms for people with AD. Researchers in this study found that nearly all significant methylation changes — small chemical tags added to DNA that help control when genes are turned on or off — were linked to the tau protein. This supports the idea that this protein plays a key role in brain cell changes tied to AD.

“Our team has previously shown that oligodendrocytes are affected in Alzheimer’s and another tau-related disease, progressive supranuclear palsy (PSP),” says the author. “These new results further highlight that problems in oligodendrocytes and myelin are central to AD. They also point to specific molecular pathways, particularly epigenetic changes, that could be targeted in future therapies.”

The study results identified new genes that may play a role in AD, including one called LDB3, and confirmed many findings across multiple independent datasets, showing its reliability. The identification of specific genes provides potential targets for future research — for example, scientists might investigate whether interventions that reverse methylation or support oligodendrocyte health can slow or modify disease progression for patients with AD. ScienceMission sciencenewshighlights.

In a study published in Nature Communications, the researchers have identified specific DNA-level changes in the brains of people with Alzheimer’s disease (AD). Using advanced biological analysis, the team mapped alterations in the brain’s regulatory landscape that may help explain why Alzheimer’s presents and progresses differently from person to person. The findings could also open new avenues for understanding other neurodegenerative diseases.

Alzheimer’s disease is the most common cause of dementia. Biologically, the disease begins with the formation of protein deposits, known as amyloid plaques, and neurofibrillary tangles in the brain. This causes brain cells to die over time and the brain to shrink. About 6.9 million people in the U.S. age 65 and older live with Alzheimer’s disease. There is no cure, and in advanced stages, complications can result in a significant decline in quality of life and death.

Continue reading “Oligodendrocyte molecular perturbations associated with tau in Alzheimer’s” | >

Enhancer dynamics and cellular architecture in the human spinal cord

Human spinal cord enhancer dynamics and cellular architecture.

The researchers present an innovative framework redefining human spinal cord cellular diversity through epigenetic configuration and spatial organization.

They identify unseen enhancer classes that define both stable cell-type identity and transitions between cells undergoing differentiation.

The authors also identify gene regulatory networks in glial cells that reorganize along the rostrocaudal axis, demonstrating anatomical differences in gene regulation.

The researchers demonstrate spatial organization of cells into distinct cellular networks and address the functional significance of this observation in the context of paracrine signaling. sciencenewshighlights ScienceMission https://sciencemission.com/Enhancer-dynamics

Kandror et al. present an innovative framework redefining human spinal cord cellular diversity through epigenetic configuration and spatial organization. They identify unseen enhancer classes, show cell-type-specific reconfiguration of gene regulatory networks along the rostrocaudal axis, and uncover cellular networks mediated by discrete paracrine signaling, challenging conventional definitions of cellular state.

Continue reading “Enhancer dynamics and cellular architecture in the human spinal cord” | >

AI finally tests a century old theory about how cancer begins

Cancer often begins when the genetic instructions that guide our cells become scrambled, allowing cells to grow uncontrollably. Now, scientists at EMBL have developed an AI-powered system called MAGIC that can automatically spot and tag cells showing early signs of chromosomal trouble—tiny DNA-filled structures known as micronuclei that are linked to future cancer development.

CRISPR the emergence of TIGR systems Rewriting DNA

Delve into the groundbreaking world of CRISPR gene editing – a technology rapidly reshaping medicine and offering unprecedented hope for treating previously incurable diseases. This video explores the remarkable journey from basic scientific curiosity about bacterial defense mechanisms to the first-ever personalized gene therapies being administered in Germany and beyond.

Discover how scientists uncovered CRISPR, an ancient bacterial immune system that functions as a precise molecular “cut-and-paste” tool for DNA. Learn about the astonishing speed at which this discovery transitioned from laboratory research to clinical applications, culminating in FDA approval of treatments for sickle cell disease and beta thalassemia – conditions once considered devastatingly difficult to manage.

We’ll examine the details of these revolutionary therapies, including how they work to correct genetic defects and provide lasting relief for patients. Beyond current successes, explore the exciting potential of CRISPR to address a wide range of inherited disorders, from hereditary angioedema to various cancers.

The video highlights the extraordinary case of KJ, an infant who received a custom-designed CRISPR base editing therapy to treat a rare metabolic disorder – demonstrating the feasibility of truly personalized medicine tailored to individual genetic profiles. Understand how this breakthrough compresses years of research into mere months, paving the way for treating countless other rare diseases.

Finally, look ahead to the future with the emergence of TIGR systems, an even more advanced class of gene-editing tools discovered in viruses that infect bacteria. These next-generation technologies promise enhanced precision, broader targeting capabilities, and potentially safer therapeutic applications. Join us as we unpack this complex science and reveal how fundamental research continues to unlock the secrets of life and offer hope for a healthier future.

#genetherapy.

Continue reading “CRISPR the emergence of TIGR systems Rewriting DNA” | >

Disorder Drives One of Nature’s Most Complex Machines

* A “Bouncer” Made of Motion: New high-resolution microscopy and computational modeling (notably a study from late 2025) reveal that the NPC’s function is driven by this very flexibility. The disordered tails constantly rearrange themselves, creating a dynamic barrier that recognizes and ushers through specific molecules while blocking harmful enzymes or misfolded RNA.

* Scientific Breakthrough: By moving beyond static “snapshots” of the pore to observing it in motion at millisecond resolution, researchers have realized that disorder, not order, is the secret to the nuclear pore’s speed and precision.

In essence, the article highlights a paradigm shift in biology: the realization that one of life’s most complex and essential machines functions not like a rigid mechanical valve, but like a flexible, chaotic filter that uses “wiggle room” to maintain the integrity of the genetic code.

Every second, hundreds to thousands of molecules move through thousands of nuclear pores in each of your cells. A new high-definition view reveals the machine in action.

Ageing promotes metastasis via activation of the integrated stress response

Ageing reprograms the evolutionary trajectory of KRAS-driven lung adenocarcinoma, limiting primary tumour growth while promoting metastatic dissemination through epigenetic activation of the integrated stress response, and a therapeutic opportunity in older patients is revealed.

Potassium channels functionality is coupled to trafficking!

In a study published recently in PNAS, researchers have revealed the relationship between KCNQ2/3 channel functionality (i.e., how well they work to control electrical signals in neurons) and localization (i.e., where they are found inside a cell), with important implications for the treatment of these epileptic disorders.

For KCNQ2/3 channels to work properly in the brain, they must have full functionality and be located in the correct cellular region – specifically the axon initial segment (AIS), the site in neurons where electric signals are first triggered, controlling nerve cell activity. This led the research team to wonder: does the functionality of KCNQ2/3 channels affect their cellular localization, or are the two not linked at all?

To investigate this potential association, the research team first genetically engineered the functionality of the channels, and then used channel trafficking imaging to visualize whether the channels were taken to their location in the AIS. In this way, they demonstrated that KCNQ2/3 functionality was indeed linked to its trafficking to the correct cellular localization. What’s more, when they used single-molecule imaging, they could see that reduced KCNQ3 functionality actually reduced the AIS localization of KCNQ2/3 by altering the entire trafficking pathway.

“Because we already knew that the localization of KCNQ2/3 to the AIS is regulated by a protein known as ankyrinG, or ankG, we next decided to explore the interactions between full-length KCNQ3 and ankG,” explains lead author of the study. “We found that the active conformation of KCNQ3 was essential for its stable binding to ankG, further confirming that functional KCNQ2/3 is needed to ensure its proper accumulation at the AIS.”

Together, these findings highlight the mechanisms underlying the important link between KCNQ2/3 functionality and localization, and provide clues about how their alterations might affect neuronal excitability. ScienceMission sciencenewshighlights.

Potassium KCNQ2/3 channels are crucial for suppressing the excitability of brain cells, or neurons. When these channels don’t work properly, they can cause specific types of epilepsy like benign familial neonatal convulsions and early infantile epileptic encephalopathy.

Continue reading “Potassium channels functionality is coupled to trafficking!” | >

/* */